Human papilloma virus treatment

A method of treating, in a subject, a disease or condition associated with a human papilloma virus (HPV), the method comprising

• administering to the subject a composition comprising a fusion protein comprising (1) an hsp, or an immunostimulatory fragment thereof, and (2) a protein of an HPV, or an antigenic fragment thereof, wherein the subject is infected with an HPV type that is different from the HPV type administered to the subject, the composition being administered in an amount sufficient to treat the disease or condition.

A method of treating, in a subject, a disease or condition associated with an HPV infection, the method comprising:

• administering to the subject a nucleic acid encoding a fusion protein comprising (1) an hsp, or an immunostimulatory fragment thereof, and (2) a protein of an HPV, wherein the subject is infected with an HPV type that is different from the HPV type administered to the subject;
• and
• expressing the fusion protein in the subject in an amount sufficient to treat the disease or condition.